KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
Currently predicting for Mon, 29 Apr 2024

Trading levels for AYTU

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 2.96 4.19 %
R2 2.90 2.13 %
R1 2.86 0.85 %
Current price: 2.84
Support S1 2.75 -3.28 %
S2 2.71 -4.56 %
S3 2.65 -6.63 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 3.15 10.92 %
R2 2.96 4.23 %
R1 2.89 1.76 %
Current price 2.84
Support S1 2.80 -1.41%
S2 2.68 -5.63%
S3 2.53 -10.92%

AYTU Predictions History

3 years ago
JS predicted that AYTU for 2021-04-06 is going $7.45 (6.73%)

3 years ago
JS predicted that AYTU for 2021-03-19 is going $9.79 (0.62%)

3 years ago
Jennifer Manguiat predicted that AYTU for 2021-03-19 is going

Rank:

3 years ago
JS predicted that AYTU for 2021-02-01 is going $7.16 (-2.19%)

3 years ago
Zohaib Ahmed predicted that AYTU for 2021-02-01 is going

Rank:

3 years ago
sander7100 yo bro predicted that AYTU for 2020-08-18 is going $1.29 (-2.27%)

3 years ago
JS predicted that AYTU for 2020-08-18 is going $1.41 (6.82%)

3 years ago
iHustle84 predicted that AYTU for 2020-08-18 is going $1.30 (-1.52%)

3 years ago
Mitch27 predicted that AYTU for 2020-08-18 is going

Rank:

3 years ago
sander7100 yo bro predicted that AYTU for 2020-08-04 is going $1.38 (-3.50%)

Click to get the best stock tips daily for free!

About Aytu Bioscience

Aytu Bioscience Aytu Biopharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel therapeutics and consumer healthcare products the United States and internationally. The company offers Adzenys XR-ODT for the treatment of attention deficit hyperactivity disorder (ADHD) in patients from 6 years and older; Cotempla XR-ODT for the treatment of ADHD in patients from 6 to 17 years old; and Adzenys ER, an oral suspension for the... AYTU Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT